Food & Medicine are life-essential products, but because of the way today's global supply chains are run, most of us do not know what we are really getting when we consume food or use medicine.
At the Ambrosus project we aim to radically improve the global supply chains by creating a trusted ecosystem where we can reliably record the entire history of products and execute commercial transactions accordingly.
We seek to enable a more secure and autonomous supply chain, improve distribution processes and allow consumers to easily see where their products come from and what is really in them.
We invite you to learn more, and to stay tuned as we provide more information over the next few months.
- Ethereum Implementation Built; Multi-Chain Impelementation in Development - Marketplace powered by Smart Contracts Built - Sensors Prototypes tested - Several Use Cases and Pilots Performed (Olive Oil, Cheese, Baby Food, Seafood) - Support from United Nations, EIT Food Swiss Federal Institute of Technology and more (Ambrosus is Official Partner to UN Sustainable Food Progamme) - Financing from the Swiss Government (Department of Economic Promotion, Canton of Vaud, Switzerland)
Attention. There is a risk that unverified members are not actually members of the team
$72 229 228
$32 229 228
$59 229 228
$42 004 155
$48 277 157
$287 826 546
Opportunities:The project has an above-average team and all-star advisors, which would legitimize the project even when the company is publicly launched only three months ago.Presale has raised around CHF 30 million already.New regulations or more stringent requirements around the distribution of specialty goods, such as medicinal products could increase demand for supply chain QA. For example, a recent change under the EU regulation, Good Distribution Practice of Medicinal Products for Human Use, requires companies to report any deviations to the distributor and the recipient of the affected medicinal products
Concerns:Food sensor and tracking is very common and lots of companies are doing it already. Ambrosus faces stiff competition in the traditional space, such as GlobeRanger, Oceansoft, and Blue Maestro, as well as in the blockchain space from Modum.The project is only launched for three months old based on the Linkedin profiles of the CEO and CTO. We feel like this project receives the attention it has solely because of Gavin Wood and other advisors. We don’t even see a picture of the hardware – the component that is essential to the Ambrosus platform.We believe Ambrosus is an average business idea, one that is difficult for the company to gain a substantial competitive advantage over other competitors and gobble up market share.Seems like the only advantage Ambrosus has over existing competitors is that data on the Ambrosus platform is incorruptible and tamperproof. However, is it really needed? We don’t believe so. Moreover, Ambrosus is creating its own blockchain. We would question the security of it because there won’t be much decentralization of nodes as there’s no incentive for independent parties to validate the transactions on the Ambrosus blockchain.Food contamination is not a very big problem that we are facing. Here is a list of major foodborne illness outbreaks. As you can see, they happen rather infrequently.
Conclusion:Overall, we are neutral on the ICO’s short-term potential and dislike its long-term potential.This project is hyped because of its advisors. All-star advisors are great for an ICO only if the project makes sense. A company that was launched three months ago raising CHF100 million to create food sensors and a related blockchain doesn’t make much sense to us. Without business fundamentals, all the advisors in the world would not help the project.Our thoughts of the tokens for short term and long term are as follows:For short-term holding:Neutral. The team of advisors really bring the awareness up. However, the hard cap of CHF 100 million is exceptionally high, especially if you consider the company is publicly launched only three months ago. The two token ICOs raising over $100 million, Bancor and Status, are both delivering negative return so far.In addition, with Modum and Ambrosus’ ICO being so close together, many investors would compare the market cap of each ($23 million for Modum and CHF 250 million for Ambrosus on a fully diluted basis if hard caps are reached). Doing so would make Ambrosus’ valuation seem that much more expensive.For long-term holding:Bad. As mentioned above, we don’t believe a blockchain solution is really necessary in the food safety supply chain space. Therefore, the chance of Ambrosus being a success is low.
This offer is based on information provided solely by the offeror and other publicly available information. The token sale or exchange event is entirely unrelated to ICOholder and ICOholder has no involvement in it (including any technical support or promotion). Token sales listed from persons that ICOholder has no relationship with are shown only to help customers keep track of the activity taking place within the overall token sector. This information is not intended to amount to advice on which you should rely. You must obtain professional or specialist advice or carry out your own due diligence before taking, or refraining from, any action on the basis of the content on our site. Any terms and conditions entered into by contributors in respect of the acquisition of Tokens are between them and the issuer of the Token and ICOholder is not the seller of such Tokens. ICOholder has no legal responsibility for any representations made by third parties in respect of any Token sale and any claim for breach of contract must also be made directly against the Token issuing entity listed herein.
If you have any concerns about the nature, propriety or legality of this token sale or the persons involved in it please contact [email protected] with detailed information about your concerns.